Thrivent Financial for Lutherans trimmed its holdings in shares of Enhabit, Inc. (NYSE:EHAB – Get Rating) by 17.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 86,065 shares of the company’s stock after selling 18,264 shares during the period. Thrivent Financial for Lutherans owned about 0.17% of Enhabit worth $1,133,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Bessemer Group Inc. bought a new stake in Enhabit during the third quarter worth approximately $26,000. Lazard Asset Management LLC acquired a new position in Enhabit in the 3rd quarter worth approximately $34,000. IFP Advisors Inc acquired a new position in Enhabit in the 3rd quarter worth approximately $39,000. South Dakota Investment Council acquired a new position in Enhabit in the 3rd quarter worth approximately $45,000. Finally, KBC Group NV acquired a new position in Enhabit in the 3rd quarter worth approximately $54,000. 95.55% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts recently commented on EHAB shares. Credit Suisse Group reaffirmed a “neutral” rating and issued a $15.00 price objective on shares of Enhabit in a research note on Thursday, February 16th. The Goldman Sachs Group started coverage on shares of Enhabit in a research note on Thursday, March 16th. They issued a “neutral” rating and a $15.00 price objective for the company. Citigroup cut their target price on shares of Enhabit from $18.00 to $15.00 in a research report on Friday, May 12th. Finally, Stifel Nicolaus increased their target price on shares of Enhabit from $17.00 to $18.00 in a research report on Wednesday, February 15th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $16.13.
Insider Buying and Selling
Enhabit Stock Up 2.4 %
Enhabit stock opened at $12.17 on Tuesday. The company has a market capitalization of $609.72 million and a P/E ratio of 15.60. The firm’s fifty day simple moving average is $13.02 and its 200-day simple moving average is $13.65. The company has a current ratio of 1.57, a quick ratio of 1.59 and a debt-to-equity ratio of 0.71. Enhabit, Inc. has a 1-year low of $11.50 and a 1-year high of $25.25.
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- monday.com Surges on Price and Volume after Blowout Results
- Can Ryanair Stock Fly Above Resistance Levels, What Earnings Show
- All Aboard! The Sell-Side Has Railroads In Reversal
- Is There Value Left in Lyft Stock?
- Everything About ZIM Integrated Screams Undervaluation
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.